Lola Fayanju (she/her, drlolafayanju@bsky.social) (@drlolafayanju) 's Twitter Profile
Lola Fayanju (she/her, [email protected])

@drlolafayanju

Chief, Division of Breast Surgery @PennSurgery @PennCancer, Assoc Director @PC3Innovation, Sr. Fellow @pennLDI. Mom, Wife, Researcher. Tweets=Mine

ID: 979015375089172482

linkhttps://www.med.upenn.edu/apps/faculty/index.php/g275/p9515189 calendar_today28-03-2018 15:20:29

3,3K Tweet

3,3K Followers

2,2K Following

PennSurgery (@pennsurgery) 's Twitter Profile Photo

President of The Society of Surgical Oncology AND our Chairman Dr Ron DeMatteo giving his first keynote 😉 at the #SSO2025 Pre-meeting Surgical Clinical Trials Primer Course.

President of The Society of Surgical Oncology AND our Chairman Dr Ron DeMatteo giving his first keynote 😉 at the #SSO2025 Pre-meeting Surgical Clinical Trials Primer Course.
PennSurgery (@pennsurgery) 's Twitter Profile Photo

#SSO2025 Presidential Dinner at the Tampa Club with Penn faculty (missing Dr’s Heather Wachtel and Giorgios Karakousis but somehow acquired Mass General Surgery Dr Ken Tanabe 😉). Will need to recreate!

#SSO2025 Presidential Dinner at the Tampa Club with Penn faculty (missing Dr’s Heather  Wachtel and Giorgios Karakousis but somehow acquired <a href="/MGHSurgery/">Mass General Surgery</a> Dr Ken Tanabe 😉). Will need to recreate!
PennSurgery (@pennsurgery) 's Twitter Profile Photo

Endocrine Surgery Section Chief Heather Wachtel presenting her excellent work on PARP-1 as a novel theranostic marker in pheochromocytoma and paraganglioma for which she won the Society of Surgical Oncology Clinical Investigator Award in 2023. #SSO2025

Endocrine Surgery Section Chief Heather Wachtel presenting her excellent work on PARP-1 as a novel theranostic marker in pheochromocytoma and paraganglioma for which she won the <a href="/SocSurgOnc/">Society of Surgical Oncology</a> Clinical Investigator Award in 2023. #SSO2025
Judy Boughey (@drjudyboughey) 's Twitter Profile Photo

Omission of surgery in patients with excellent response to neoadjuvant chemotherapy shows no recurrences at 5 years. ⁦Henry Kuerer⁩ leads the research on this new paradigm. #SSO2025. ⁦Mayo Clinic Comprehensive Cancer Center⁩ delighted to be participating in this important trial.

Omission of surgery in patients with excellent response to neoadjuvant chemotherapy shows no recurrences at 5 years. ⁦<a href="/HenryKuerer/">Henry Kuerer</a>⁩ leads the research on this new paradigm. #SSO2025. ⁦<a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a>⁩ delighted to be participating in this important trial.
PennSurgery (@pennsurgery) 's Twitter Profile Photo

Julia Tchou, MD, PhD, Lola Fayanju, MD, MA, MPHS, and Jennifer Q. Zhang, MD, are representing the Penn Breast Surgical Oncology Fellowship Program at the 2025 SSO meeting in Tampa, FL  #SSO2025 #SSOCommunity #SSO

Julia Tchou, MD, PhD, Lola Fayanju, MD, MA, MPHS, and Jennifer Q. Zhang, MD, are representing the Penn Breast Surgical Oncology Fellowship Program at the 2025 SSO meeting in Tampa, FL  #SSO2025 #SSOCommunity #SSO
Michigan Surgery (@umichsurgery) 's Twitter Profile Photo

Congratulations to Jacqueline Jeruss, MD, PhD, who has been installed as the inaugural Alfred E. Chang, MD, Research Professor in Surgical Oncology!

Congratulations to Jacqueline Jeruss, MD, PhD, who has been installed as the inaugural Alfred E. Chang, MD, Research Professor in Surgical Oncology!
PennSurgery (@pennsurgery) 's Twitter Profile Photo

New study led by Kriyana Reddy and Lola Fayanju (she/her, [email protected]) finds that increased distance to care prolongs time to surgery (TTS) for rural patients with breast cancer. But rurality, independent of distance, has an intrinsic protective effect on TTS. journals.lww.com/annalsofsurger…

Kimryn Rathmell (@kimrynrathmell) 's Twitter Profile Photo

I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3

Fumiko Ladd Chino, MD, FASCO (@fumikochino) 's Twitter Profile Photo

🎙️It's not one size fits all with cancer care. We're trying to make a customized plan & [rally] all of the modern technologies to make sure that we're rightsizing the treatments for the individual. And I think that provides a lot of benefits for patients. #breastCancer #bcsm

🎙️It's not one size fits all with cancer care. We're trying to make a customized plan &amp; [rally] all of the modern technologies to make sure that we're rightsizing the treatments for the individual.

And I think that provides a lot of benefits for patients.

#breastCancer #bcsm
Miriam Mutebi (@m_mutebi) 's Twitter Profile Photo

Africa represents <5% of participants in global #oncology trials, despite its rich genetic diversity. Clinical trials shouldn't leave Africa behind. Read why here: tinyurl.com/CROPPDMeet #KeepingAbreastWithDrMiriam AORTIC ASCO

Dr Liz O'Riordan (@liz_oriordan) 's Twitter Profile Photo

HELP! Where can we source photos of women with brown and black skin who have inflammatory cancer? Breast redness is easy to see on white skin Heard from 2 ladies educating women in Uganda where resources are scarce. They need tools to show women what the signs of breast cancer

LauraRosenbergerMD (@rosenbergermd) 's Twitter Profile Photo

Brilliant study by Shayna Showalter UVA Surgery. POWER trial of 90-day PRE-op 🔪endocrine therapy 💊 to assess tolerance before decision re: RT omission. Early improved endocrine compliance. ASBrS #ASBrS2025 POWER2 enrolling! 🎉

Brilliant study by <a href="/shaynalefrak/">Shayna Showalter</a> <a href="/UVASurgery/">UVA Surgery</a>. POWER trial of 90-day PRE-op 🔪endocrine therapy 💊 to assess tolerance before decision re: RT omission. Early improved endocrine compliance. <a href="/ASBrS/">ASBrS</a> #ASBrS2025  POWER2 enrolling! 🎉
OncLive.com (@onclive) 's Twitter Profile Photo

Registration is open! Join Lola Fayanju (she/her, [email protected]) of Penn Medicine - Abramson Cancer Center as she chairs an OncLive® SOSS in Philadelphia! Featuring a powerhouse panel melissa mcshane MD, Amy Clark, MD, Emily Ko, MD, Lainie Martin, MD, & Mark Shahin, MD. Register Now: hubs.li/Q03l42Md0 Fox Chase Cancer Center

Registration is open! Join <a href="/DrLolaFayanju/">Lola Fayanju (she/her, drlolafayanju@bsky.social)</a> of <a href="/PennCancer/">Penn Medicine - Abramson Cancer Center</a> as she chairs an OncLive® SOSS in Philadelphia! Featuring a powerhouse panel <a href="/melmcshaneMD/">melissa mcshane MD</a>, Amy Clark, MD, Emily Ko, MD, Lainie Martin, MD, &amp; Mark Shahin, MD.
Register Now: hubs.li/Q03l42Md0 <a href="/FoxChaseCancer/">Fox Chase Cancer Center</a>